Agency Information Collection Activities; Proposed Collection; Comment Request; Health and Diet Survey, as Used by the Food and Drug Administration, 32832-32834 [2017-15001]
Download as PDF
<![CDATA[
32832
Federal Register / Vol. 82, No. 136 / Tuesday, July 18, 2017 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued
Activity
Number of
respondents
FDA Form
Number of
responses per
respondent
Total annual
responses
Average burden
per response
Total hours
Special drug experience reports,
§ 514.80(b)(5)(i).
Submission of advertisements and
promotional
labeling,
§ 514.80(b)(5)(ii).
Submission of distributor statements,
§ 514.80(b)(5)(iii).
2301
200
0.57
114
2 ...........................
228
2301
200
20.12
4,024
2 ...........................
8,048
2301
190
0.1
19
2 ...........................
38
Total ...........................................
........................
........................
........................
........................
..............................
36,246.25
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
We base our reporting estimates on
our experience with adverse event
reporting for approved new animal
drugs and the number of reports
received in the previous 3 years.
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of
recordkeepers
Activity
Number of
records per
recordkeeper
Total annual
records
Average
burden per
recordkeeping
Total hours
Recordkeeping, § 510.301 2 .................................................
Recordkeeping, 21 U.S.C. 360b(l) and § 514.80(e) 3 ..........
5
646.70
1
7.19
5
4,649.8
4
14
20
65,097
Total ..............................................................................
........................
........................
........................
........................
65,117
1 There
2 This
sradovich on DSK3GMQ082PROD with NOTICES
3 This
are no capital costs or operating and maintenance costs associated with this collection of information.
estimate includes all recordkeeping by licensed medicated feed manufacturers under § 510.301.
estimate includes all recordkeeping by applicants of approved NADAs, ANADAs, and CNADAs under § 514.80(e).
We base our recordkeeping estimates
on our experience with adverse event
reporting for approved new animal
drugs and the number of reports
received in the previous 3 years. Since
the consolidation of the 0910–0012
collection into this collection in 2004,
we have included the estimated
recordkeeping burden for medicated
feed adverse event reports as part of our
estimate of the recordkeeping burden of
all mandatory adverse event reports for
new animal drugs. To improve the
clarity of our estimates we have added
a row to table 2, on which we separately
report our recordkeeping estimate for
medicated feed adverse event reports
(20 hours).
The burden of this collection has
changed. Due to the addition of a new
row to table 1 and a new row to table
2, there was a slight increase in the
estimated number of reports submitted
to FDA under total annual responses (by
7.8 responses). The overall decrease in
burden hours (by 1.75 hours) is due to
the normal variation in the submission
of reports to FDA.
We continually strive to improve our
systems for collecting and analyzing
drug experience reports and adverse
event reports. To that end, we have
developed an electronic submission
system by which Form FDA 2301 may
VerDate Sep<11>2014
17:47 Jul 17, 2017
Jkt 241001
be submitted to the Agency. For Form
FDA 1932a, we have a fillable electronic
form available online, which can be
submitted by email to FDA Center for
Veterinary Medicine. We specifically
invite comment from respondents on
the utility of these reporting forms.
Electronic adverse event reporting for
approved new animal drugs (including
mandatory reporting under § 514.80(b)
and voluntary reporting) has been
approved under OMB control number
0910–0645. Reporting and
recordkeeping associated with the index
of legally marketed unapproved new
animal drugs for minor species (21 CFR
part 516) is approved under OMB
control number 0910–0620.
Dated: July 11, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–14993 Filed 7–17–17; 8:45 am]
BILLING CODE 4164–01–P
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0920]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Health and Diet
Survey, as Used by the Food and Drug
Administration
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the Health and
Diet Survey as used by FDA to gauge
and to track consumer attitudes,
awareness, knowledge, and behavior
SUMMARY:
E:\FR\FM\18JYN1.SGM
18JYN1
Federal Register / Vol. 82, No. 136 / Tuesday, July 18, 2017 / Notices
regarding various topics related to
health, nutrition, physical activity, and
product labeling.
DATES: Submit either electronic or
written comments on the collection of
information by September 18, 2017.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before September 18,
2017. The https://www.regulations.gov
electronic filing system will accept
comments until midnight Eastern Time
at the end of September 18, 2017.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
sradovich on DSK3GMQ082PROD with NOTICES
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
VerDate Sep<11>2014
17:47 Jul 17, 2017
Jkt 241001
Instructions: All submissions received
must include the Docket No. FDA–
2014–N–0920 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request; Health
and Diet Survey, as Used by the Food
and Drug Administration.’’ Received
comments, those filed in a timely
manner (see ADDRESSES), will be placed
in the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A63, 11601 Landsdown
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
32833
St., North Bethesda, MD 20852, 301–
796–7726, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Health and Diet Survey as Used by the
Food and Drug Administration OMB
Control Number 0910–0545—Extension
We are seeking to renew OMB
approval of the Health and Diet Survey,
which is a voluntary consumer survey
intended to gauge and to track consumer
attitudes, awareness, knowledge, and
behavior regarding various topics
related to health, nutrition, physical
activity, and product labeling. OMB
approved this collection as a generic
collection on December 5, 2014. The
authority for FDA to collect the
information derives from FDA’s
Commissioner of Food and Drugs
authority provided in section 1003(d)(2)
of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 393(d)(2)).
We will use the Health and Diet
Survey findings to test and refine our
ideas, but will generally conduct further
E:\FR\FM\18JYN1.SGM
18JYN1
32834
Federal Register / Vol. 82, No. 136 / Tuesday, July 18, 2017 / Notices
research before making important
decisions such as adopting new policies
and allocating or redirecting significant
resources to support these policies.
This survey has been repeated
approximately every 3 to 5 years over
the course of the past 3 decades for the
purpose of tracking changes and trends
in public opinions and consumer
behavior, with some new questions
added or omitted or partially modified
in each iteration in response to
emerging and current events or issues.
In the next 3 years, we plan to field this
survey two to three times. We will use
the information from the Health and
Diet Survey to evaluate and develop
strategies and programs to encourage
and help consumers adopt healthy diets
and lifestyles. The information will also
help FDA evaluate and track consumer
awareness and behavior as outcome
measures of their achievement in
improving public health.
Description of Respondents: The
respondents are adults, age 18 and
older, drawn from the 50 States and the
District of Columbia. Participation will
be voluntary.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Activity
Number of
responses per
respondent
Average
burden per
response
Total annual
responses
Total hours
Cognitive interview screener ....................................
Cognitive interview ...................................................
Pretest screener .......................................................
Pretest ......................................................................
Survey screener .......................................................
Survey ......................................................................
100
18
2,000
200
40,000
4,000
1
1
1
1
1
1
100
18
2,000
200
40,000
4,000
0.08 (5 minutes) ........
1 ................................
0.033 (2 minutes) ......
0.25 (15 minutes) ......
0.033 (2 minutes) ......
0.25 (15 minutes) ......
8
18
66
50
1,320
1,000
Total ..................................................................
........................
........................
........................
....................................
2,462
sradovich on DSK3GMQ082PROD with NOTICES
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
We base our estimate of the number
of respondents and the average burden
per response on our experience with
previous Health and Diet Surveys and
we estimate that the burden for this
information collection has increased by
580 hours (from 1,882 to 2,462 hours)
since the last OMB approval. The
increase is due to an expected increase
in the number of participants
completing the survey screener (from
30,000 to 40,000 participants) and
number of participants taking the survey
(from 3,000 to 4,000). We will use a
cognitive interview screener with 100
individuals to recruit prospective
interview participants. We estimate that
it will take a screener respondent
approximately 5 minutes (0.08 hours) to
complete the cognitive interview
screener, for a total of 8 hours. We will
conduct cognitive interviews with 18
participants. We estimate that it will
take a participant approximately 1 hour
to complete the interview, for a total of
18 hours. Prior to the administration of
the Health and Diet Survey, the Agency
plans to conduct a pretest to identify
and resolve potential survey
administration problems. We will use a
pretest screener with 2,000 individuals;
we estimate that it will take a
respondent approximately 2 minutes
(0.033 hours) to complete the pretest
screener, for a total of 66 hours. The
pretest will be conducted with 200
participants; we estimate that it will
take a participant 15 minutes (0.25
hours) to complete the pretest, for a total
of 50 hours. We will use a survey
screener to select an eligible adult
VerDate Sep<11>2014
17:47 Jul 17, 2017
Jkt 241001
respondent in each household reached
by landline telephone numbers to
participate in the survey. A total of
40,000 individuals in the 50 states and
the District of Columbia will be
screened by telephone. We estimate that
it will take a respondent 2 minutes
(0.033 hours) to complete the screening,
for a total of 1,320 hours. We estimate
that 4,000 eligible adults will participate
in the survey, each taking 15 minutes
(0.25 hours), for a total of 1,000 hours.
Thus, the total estimated burden is
2,462 hours.
We are requesting this burden for
unplanned surveys so as not to restrict
our ability to gather information on
consumer attitudes, awareness,
knowledge, and behavior regarding
various topics related to health,
nutrition, physical activity, and product
labeling. This ability will help the
Agency identify and respond to
emerging issues in a more timely
manner.
Dated: July 11, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–15001 Filed 7–17–17; 8:45 am]
BILLING CODE 4164–01–P
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0598]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Current Good
Manufacturing Practice Regulations for
Type A Medicated Articles
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing that a proposed collection
of information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by August 17,
2017.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0154. Also
include the FDA docket number found
in brackets in the heading of this
document.
SUMMARY:
E:\FR\FM\18JYN1.SGM
18JYN1
]]>Agencies
[Federal Register Volume 82, Number 136 (Tuesday, July 18, 2017)]
[Notices]
[Pages 32832-32834]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15001]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-0920]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Health and Diet Survey, as Used by the Food and Drug
Administration
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the Health and Diet Survey as used by FDA
to gauge and to track consumer attitudes, awareness, knowledge, and
behavior
[[Page 32833]]
regarding various topics related to health, nutrition, physical
activity, and product labeling.
DATES: Submit either electronic or written comments on the collection
of information by September 18, 2017.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before September 18, 2017. The https://www.regulations.gov electronic filing system will accept comments until
midnight Eastern Time at the end of September 18, 2017. Comments
received by mail/hand delivery/courier (for written/paper submissions)
will be considered timely if they are postmarked or the delivery
service acceptance receipt is on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2014-N-0920 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Health and Diet Survey, as Used
by the Food and Drug Administration.'' Received comments, those filed
in a timely manner (see ADDRESSES), will be placed in the docket and,
except for those submitted as ``Confidential Submissions,'' publicly
viewable at https://www.regulations.gov or at the Dockets Management
Staff between 9 a.m. and 4 p.m., Monday through Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A63, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Health and Diet Survey as Used by the Food and Drug Administration OMB
Control Number 0910-0545--Extension
We are seeking to renew OMB approval of the Health and Diet Survey,
which is a voluntary consumer survey intended to gauge and to track
consumer attitudes, awareness, knowledge, and behavior regarding
various topics related to health, nutrition, physical activity, and
product labeling. OMB approved this collection as a generic collection
on December 5, 2014. The authority for FDA to collect the information
derives from FDA's Commissioner of Food and Drugs authority provided in
section 1003(d)(2) of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 393(d)(2)).
We will use the Health and Diet Survey findings to test and refine
our ideas, but will generally conduct further
[[Page 32834]]
research before making important decisions such as adopting new
policies and allocating or redirecting significant resources to support
these policies.
This survey has been repeated approximately every 3 to 5 years over
the course of the past 3 decades for the purpose of tracking changes
and trends in public opinions and consumer behavior, with some new
questions added or omitted or partially modified in each iteration in
response to emerging and current events or issues. In the next 3 years,
we plan to field this survey two to three times. We will use the
information from the Health and Diet Survey to evaluate and develop
strategies and programs to encourage and help consumers adopt healthy
diets and lifestyles. The information will also help FDA evaluate and
track consumer awareness and behavior as outcome measures of their
achievement in improving public health.
Description of Respondents: The respondents are adults, age 18 and
older, drawn from the 50 States and the District of Columbia.
Participation will be voluntary.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Activity Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Cognitive interview screener................ 100 1 100 0.08 (5 minutes).......................... 8
Cognitive interview......................... 18 1 18 1......................................... 18
Pretest screener............................ 2,000 1 2,000 0.033 (2 minutes)......................... 66
Pretest..................................... 200 1 200 0.25 (15 minutes)......................... 50
Survey screener............................. 40,000 1 40,000 0.033 (2 minutes)......................... 1,320
Survey...................................... 4,000 1 4,000 0.25 (15 minutes)......................... 1,000
-----------------------------------------------------------------------------------------------------------
Total................................... .............. .............. .............. .......................................... 2,462
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
We base our estimate of the number of respondents and the average
burden per response on our experience with previous Health and Diet
Surveys and we estimate that the burden for this information collection
has increased by 580 hours (from 1,882 to 2,462 hours) since the last
OMB approval. The increase is due to an expected increase in the number
of participants completing the survey screener (from 30,000 to 40,000
participants) and number of participants taking the survey (from 3,000
to 4,000). We will use a cognitive interview screener with 100
individuals to recruit prospective interview participants. We estimate
that it will take a screener respondent approximately 5 minutes (0.08
hours) to complete the cognitive interview screener, for a total of 8
hours. We will conduct cognitive interviews with 18 participants. We
estimate that it will take a participant approximately 1 hour to
complete the interview, for a total of 18 hours. Prior to the
administration of the Health and Diet Survey, the Agency plans to
conduct a pretest to identify and resolve potential survey
administration problems. We will use a pretest screener with 2,000
individuals; we estimate that it will take a respondent approximately 2
minutes (0.033 hours) to complete the pretest screener, for a total of
66 hours. The pretest will be conducted with 200 participants; we
estimate that it will take a participant 15 minutes (0.25 hours) to
complete the pretest, for a total of 50 hours. We will use a survey
screener to select an eligible adult respondent in each household
reached by landline telephone numbers to participate in the survey. A
total of 40,000 individuals in the 50 states and the District of
Columbia will be screened by telephone. We estimate that it will take a
respondent 2 minutes (0.033 hours) to complete the screening, for a
total of 1,320 hours. We estimate that 4,000 eligible adults will
participate in the survey, each taking 15 minutes (0.25 hours), for a
total of 1,000 hours. Thus, the total estimated burden is 2,462 hours.
We are requesting this burden for unplanned surveys so as not to
restrict our ability to gather information on consumer attitudes,
awareness, knowledge, and behavior regarding various topics related to
health, nutrition, physical activity, and product labeling. This
ability will help the Agency identify and respond to emerging issues in
a more timely manner.
Dated: July 11, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-15001 Filed 7-17-17; 8:45 am]
BILLING CODE 4164-01-P
